Globus Medical Inc (GMED) Stock Price & Analysis

Globus Medical Inc (GMED) rose 0.00% to USD 76.49 as of July 25, 2026 at 03:42 UTC, according to Nexqual real-time market data.

GMED last closed at USD 76.49; the session ranged USD 75.17–77.41 on volume of 1,707,084 shares. Market capitalization is —, with a 52-week range of USD 51.79–101.4 (NYQ). Source: Nexqual, July 25, 2026 at 03:42 UTC.

Key Statistics (as of July 25, 2026 at 03:42 UTC)

Technical Analysis (GMED)

Nexqual's technical model rates GMED "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 03:42 UTC.

From Globus Medical Inc's Latest SEC 10-K Filing (filed 2026-02-24)

Key Strengths & Strategy (as disclosed to the SEC)

• We, and our third-party manufacturers, are subject to the quality system regulations of the FDA, state regulations (such as the regulations promulgated by the California Department of Health Services), and regulations promulgated by foreign regulatory bodies (such as in the European Union (the "EU")).
• Food and Drug Administration Regulation Our products meet the FDA's definition of medical devices (per Section 201(h)(1) of the Food, Drug, and Cosmetic Act) and human tissue products (under 21 CFR Parts 1270 and 1271 or Public Health Service Act Section 361), each subject to varying regulation(s) by the FDA and other federal, state, local and foreign regulatory bodies.
• Certain HCT/Ps are regulated solely under Section 361 of the Public Health Service Act and are referred to as "Section 361 HCT/Ps," while other HCT/Ps are subject to the FDA's regulatory requirements for medical devices or biologics in addition to the regulatory requirements under 21 CFR Parts 1270 and 1271.
• Our surgeon education and training program integrates surgical training with professional development and enables us to introduce surgeons to our comprehensive portfolio and patented approaches to spine surgery.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:42 UTC. This page is informational and not investment advice.